Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow INTEGRATED BIOPHARMA INC

Get SEC filing alerts via email and in your feed for INTEGRATED BIOPHARMA INC

INBP

INTEGRATED BIOPHARMA INC

About INTEGRATED BIOPHARMA INC

Integrated BioPharma, Inc. manufactures, distributes, and markets vitamins, nutritional supplements, and herbal products primarily for customers in the U.S. and Luxembourg. Its core segments include contract manufacturing and related services, serving health and wellness markets. The company emphasizes product quality, regulatory compliance, and niche market focus, operating with a small, experienced team and leveraging strategic supplier relationships in a highly competitive industry.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from INTEGRATED BIOPHARMA INC

1
1
INTEGRATED BIOPHARMA INC Integrated BioPharma Reports 27.5% Decline in Q3 Revenue, Net Loss of $837,000

Via official filing (AI summary) | 27 days ago | 0 comments

2
1
INTEGRATED BIOPHARMA INC Integrated BioPharma Reports 10.6% Revenue Decline in Q2 Fiscal 2026

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
INTEGRATED BIOPHARMA INC Integrated BioPharma Reports Decline in Net Sales and Income for Quarter Ending September 30, 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
INTEGRATED BIOPHARMA INC Integrated BioPharma Reports 8% Net Sales Increase to $54.4 Million for Fiscal Year Ending June 30, 2025

Via official filing (AI summary) | 8 months ago | 0 comments

5
1
INTEGRATED BIOPHARMA INC Integrated BioPharma Reports Net Income Growth and Revenue Increase for Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
INTEGRATED BIOPHARMA INC Integrated BioPharma Reports Net Income of $116,000 for Q4 2024, Revenue Increases 9.6%

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
INTEGRATED BIOPHARMA INC Integrated Biopharma Reports 5.4% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments